NEWRONIKA SECURES 2.5 MILLION EUROS GRANT FROM EIC ACCELERATOR
The amounts will be used to fund European pivotal clinical trial in adaptive deep brain stimulation to improve the lives of Parkinson’s disease
INDACO VENTURE PARTNERS – PRIMO INVESTIMENTO DEL FONDO INDACO BIO NEL ROUND DI FINANZIAMENTO DI 23 MILIONI DI EURO IN SIBYLLA BIOTECH
Milano, 4 ottobre 2022 – Indaco Venture Partners SGR, uno dei principali operatori indipendenti italiani di venture capital, annuncia oggi il primo investimento
INDACO VENTURE PARTNERS – INDACO BIO FUND FIRST CLOSING AT 95 MILLION EUROS
Indaco Venture Partners SGR expands its area of investment activity in biotech and drug development with a dedicated Fund and an experienced team
ALMAWAVE ACQUIRES 100% OF THE DATA APPEAL COMPANY S.P.A.
Rome, April 13, 2022 - Almawave S.p.A., an Italian company listed on the Euronext Growth Milan (Ticker:AIW) and part of the Almaviva Group,
Indaco Venture Partners SGR is awarded “Best Venture Capital Asset Manager – Italy 2021” by CFI.co
Indaco Venture Partners SGR has been awarded the: “Best Venture Capital Asset Manager Italy 2021” by cfi.co based on its “diverse and highly
D-Orbit to Combine with Breeze Holdings and become a Publicly Listed Company
D-Orbit S.p.A., a Market Leader in Space Logistics, to Combine with Breeze Holdings Acquisition Corp. and Become a Publicly Listed Company Press release: Link
BENDIT: SUCCESSFUL FIRST-IN-HUMAN USE NEUROVASCULAR CATHETER
BENDIT Technologies, a company focused on the development of steerable microcatheters, announced today the successful first use in the USA of the BENDIT21 neuro catheter
Almawave to acquire The Data Appeal Company
Indaco is happy to announce the signing of a binding agreement with Almawave for the sale of 100% of the subsidiary The Data
Indaco receives the early stage category award at the XVIII edition of the Claudio Dematté Private Equity of the Year Award for the PileGrowthTech / Ascatron exit
Indaco has been awarded at the 18th edition of the Claudio Dematté Private Equity of the Year Award, promoted by AIFI - Associazione
CellPly: 2mln euros round
CLOSED TWO MILLION ROUND FOR CELLPLY, THE TECHNOLOGY THAT REVOLUTIONIZES THE CHARACTERIZATION OF CELL THERAPIES for more info: link
D-Orbit: growth in hiring and orders
Being the largest investor in D-Orbit, we are proud of its great success.The #space infrastructure pioneer registered a strong growth in the last four years. With
